What You Should Know:
- PathAI, a pioneer in AI-powered digital pathology, has achieved a significant milestone with the CE mark certification of its AISight Dx Image Management System (IMS) for primary diagnosis.
- The certification paves the way for PathAI's expansion into the European diagnostic pathology market, offering pathologists a powerful tool to enhance their interpretations and improve laboratory efficiency.
AISight Dx: A Comprehensive Digital Pathology
Read More
PathAI
PathAI and ConcertAI Partner to Create Histopathology & Clinical RWD Solutions
What You Should Know:
PathAI, a provider of AI-powered pathology, and ConcertAI, an AI software-as-a-service (SaaS) technology and real-world evidence (RWE) solutions for life sciences and healthcare, today announced a strategic partnership to launch a first-in-class quantitative histopathology and curated clinical real-world data (RWD) solution.The solution combines PathAI's PathExplore™ tumor microenvironment panel with ConcertAI's Patient360™ and RWD360™
Read More
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?
News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments.
Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More
KLAS: State of Digital Pathology Among Early Adopters in 2022
What You Should Know:
- In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction.
- 33 of the interviewed organizations are live with
Read More
PathAI and GlaxoSmithKline Partner to Accelerate Research and Drug Development
What You Should Know:
- PathAI and GSK announced a multi-year strategic artificial intelligence (AI) partnership today with a focus on accelerating research and- building drug development programs in oncology and non-alcoholic steatohepatitis (NASH).
- As part of the partnership, GSK will leverage both PathAI’s expertise and models to advance GSK’s proprietary AI models and focus on designing better models to deliver improved treatment options for patients with cancer
Read More
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
3 AI Trends for 2020: Moving Beyond Dazzle to High-Impact Collaboration
From the first artificial skin to driverless cars that navigate busy streets with ease, 2019 brought a dazzling array of artificial intelligence (AI) discovery. In 2020, the progress made toward AI-fueled collaboration will be as critical as AI innovation—especially in healthcare.
We’ve reached a point where AI has proven its utility. In radiology, for example, AI is well-oriented to interpret diagnostic imaging studies, with FDA approval given to AI algorithms that diagnose a collapsed lung or
Read More
Analysis: November 2019 Health IT M&A Activity, Public Company Performance
– Healthcare Growth Partners' (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of November 2019We did a doubletake when we noticed all of the HGP healthcare indices climbed approximately 10% during the month of November. Year-to-date, the S&P 500 is up over 25% and the HGP healthcare indices are all hovering in that range. In the two month period since September, when talk of universal healthcare reached
Read More
CB Insights Unveils ‘Digital Health 150’ List of Startups Transforming Healthcare
- CB Insights unveils first-ever annual ‘Digital Health 150’ list of digital health startups working to transform the healthcare industry.
- The Digital Health 150 companies span a wide spectrum of categories that involve all three key stakeholder groups for the healthcare industry — providers, payers, and patients.
- A total of 17 companies on the list are unicorns (private companies valued at $1B+). Of these, 12 companies are US-based, 3 are based in China, 1 is based in France, and 1
Read More
PathAI Lands $60M to Accelerate AI-Powered Pathology Platform
PathAI, a Boston, MA-based provider of AI-powered pathology platform has raised $60M in Series B funding led by General Atlantic with strong participation from General Catalyst and other existing investors. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors.Advanced Learning Towards Faster More Accurate Diagnosis of DiseaseCo-founded by Chief Executive Officer Dr. Andy Beck in 2016 with the mission to offer faster, safer and more powerful solutions
Read More
